Hall 2003.
Study characteristics | ||
Methods | Quasi‐randomised controlled trial, parallel group (1:1) | |
Participants | Participants aged 35‐75 years, with type 2 diabetes mellitus and no history of CVD or renal disease attending a specialised diabetes mellitus clinic in the UK Inclusion criteria: not reported Exclusion criteria: not reported 323 participants recruited (n = 162 intervention, n = 161 comparison) Mean age of participants not reported; 48% women; 100% diabetes mellitus |
|
Interventions | The New Zealand cardiovascular risk score was calculated for all participants Intervention group: CVD risk score was documented on the front of the participant's chart before visit Comparison group: no risk score documentation |
|
Outcomes | Primary outcome: not specified Outcomes reported: changes in diabetes mellitus treatment, changes in antihypertensive treatment, referral to dietician, risk score mentioned in letter to GP Follow‐up: none |
|
Study funding sources | Funding source not reported by authors | |
Notes | — | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | High risk | "We allocated patients alternately to experimental and control groups." |
Allocation concealment (selection bias) | High risk | See above |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Not blinded |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Method for outcome assessment not reported |
Incomplete outcome data (attrition bias) All outcomes | Low risk | All participants included in study were analysed |
Selective reporting (reporting bias) | Unclear risk | No protocol available for review |
Other bias | High risk | Small study bias |